At Regenerative Neuropathy, highly trained doctors are using a cutting-edge treatment and successfully slowing and often reversing the disease without addictive medications. The next 15 callers ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

Manur Multi Specialty Hospital successfully treats 14-year-old boy with Guillain-Barre Syndrome, AMSAN, and breathing issues.

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

The complement inhibitors market is gaining momentum due to the rising recognition of the complement system's role in driving rare and chronic diseases, such as paroxysmal nocturnal hemoglobinuria ...

A recent study by Dr. Jordan Verplank, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the ...

Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN ... At the moment treatment is limited to drugs like gabapentin and ...

Laura Begley Bloom on Studio 3.

The Bcl-2 inhibitor venetoclax is highly effective and is another first- or second-line option even if this agent, like BTK inhibitors, also appears to require continuous dosing, said Stadtmauer, ...

The Waltham Forest home treatment team (HTT) provides acute home treatment for adults aged 16-65 whose mental health crisis is so severe that they would otherwise have been admitted to a hospital.

While conservative treatment can be done at home, it's important to see the vet before starting as there are other conditions that may mimic a pinched nerve such as other neurological disorders or ...